Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Type 3C diabetes is a distinct condition needing more research and treatment strategies.

The chitosan-peptide system helps cartilage regeneration using fat-derived cells.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Early diagnosis and coordinated care are crucial for managing lupus effectively.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Both HLA-B and MICA are independently linked to alopecia areata.

Certain genetic factors may contribute to frontal fibrosing alopecia in Brazil.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Vogt-Koyanagi-Harada disease affects vision and skin, mainly in people with darker skin, and is treated with steroids and immunosuppressants.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

The hepatitis B vaccine did not cause hair loss in the tested mice.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Most women with ankylosing spondylitis tested positive for HLA-B27, suggesting it's useful for diagnosis.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The patient with Ankylosing Spondylitis had shoulder joint damage and bone changes.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Stem cell vesicles can reduce skin aging from UVB by lowering inflammation and oxidative stress.